Actively Recruiting

Phase 2
Age: 40Years - 85Years
All Genders
NCT06842745

Transcranial Magnetic Stimulation + Language Therapy to Treat Mild Aphasia

Led by University of Pennsylvania · Updated on 2026-03-05

24

Participants Needed

1

Research Sites

80 weeks

Total Duration

On this page

Sponsors

U

University of Pennsylvania

Lead Sponsor

T

Temple University

Collaborating Sponsor

AI-Summary

What this Trial Is About

The goal of this clinical trial is to determine if Transcranial Magnetic Stimulation (TMS) combined with Speech-Language Therapy (SLT) is an effective treatment for mild aphasia in persons with chronic stroke. The main questions this study aims to answer are: 1. Can TMS combined with SLT improve conversational speech and comprehension? 2. Can we identify specific behavioral and biological characteristics that would benefit most from the TMS and SLT treatment? Researchers will compare real TMS to sham (fake) TMS to see whether TMS can treat post-stroke mild aphasia. Participants will: * Complete a screening and medical intake to determine eligibility * Undergo a MRI * Participate in 10 consecutive sessions (Monday-Friday) of TMS and SLT treatment * Complete follow-up assessments 2 and 4 months after treatment

CONDITIONS

Official Title

Transcranial Magnetic Stimulation + Language Therapy to Treat Mild Aphasia

Who Can Participate

Age: 40Years - 85Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Left Hemisphere stroke
  • Stroke occurred more than 6 months ago
  • Mild Aphasia (WAB AQ score > 85)
  • Proficient in English
Not Eligible

You will not qualify if you...

  • Ongoing substance or alcohol abuse
  • Other neurological disorders besides stroke (e.g., dementia, traumatic brain injury, multiple sclerosis)
  • Active psychiatric disorders (e.g., bipolar disorder, schizophrenia)
  • Pacemaker or cardiac defibrillator
  • Diagnosis of tinnitus
  • Epilepsy or seizure in the past 6 months

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University of Pennsylvania

Philadelphia, Pennsylvania, United States, 19014

Actively Recruiting

Loading map...

Research Team

H

Harris Drachman, MS

CONTACT

D

Daniela Sacchetti, MS

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

TRIPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here